Staphylococcus haemolyticus is frequently cultured from hospitalized patients and is characterized by resistance to multiple antimicrobial agents. We found that S. haemolyticus represented 70 of 524 (13%) coagulase-negative staphylococcal isolates identified by the clinical microbiology laboratories of two hospitals over 2 months. S. haemolyticus isolates were recovered from wounds (44%), urine (26%), blood (10%), and other sources (20%). All S. haemolyticus isolates were tested for susceptibility to six antimicrobial agents; 77% were resistant to three or more agents, and 41% were resistant to five or six agents. In addition, among 47 multiply resistant isolates, high MICs (.6.25 ,ug/ml) of vancomycin (62% of isolates) and teicoplanin (91% of isolates) were found. DNA probes which were derived from S. epidermidis or S. aureus and which contained sequences associated with resistance to antimicrobial agents were used to detect specific genes in the total cellular and plasmid DNAs of 10 resistant S. haemolyticus isolates. Resistance gene probes and the numbers of resistant isolates hybridizing were as follows: methicillin, 10 of 10; gentamicin, 9 of 10; erythromycin, 7 of 10; and trimethoprim, 0 of 10. Genes for resistance to methicillin were found only in chromosomal locations, genes for resistance to gentamicin were found in both chromosomal and plasmid locations, and genes for resistance to erythromycin were found in plasmid locations only. With the exception of trimethoprim resistance determinants, similar genes were found among concurrently isolated multiply resistant S. epidermidis isolates from our hospitals. S. haemolyticus is a potentially important nosocomial species which readily acquires antimicrobial resistance genes and which shares, to some extent, in a common gene pool with S. epidermidis.Staphylococcus haemolyticus has been reported to represent an average of 10% of clinical coagulase-negative staphylococcal isolates (5,7,9,12,15,22,24,25,27,28). Many of these isolates have been found to be resistant to multiple antimicrobial agents. The importance of these organisms as human pathogens relative to that of other coagulase-negative staphylococci is uncertain, in part because species determinations of coagulase-negative staphylococci are not routinely done in most clinical microbiology laboratories. The mechanisms of antimicrobial resistance in S. haemolyticus and the extent to which it shares resistance genes with other staphylococci are also unknown. In a recent study of trimethoprim resistance among coagulase-negative staphylococci (6), we found that a specific trimethoprim resistance gene probe from a conjugative S. aureus plasmid hybridized with all trimethoprim-resistant S. epidermidis isolates but not with four S. haemolyticus isolates tested. The possibility of unique mechanisms of resistance in this poorly understood species led us to further investigate its characteristics.In the present study, we determined the proportion of S. haemolyticus isolates among clinical isolates of coagulasenega...